member of Partners OS, may be deemed to beneficially own the 4,274,965 shares beneficially owned in the aggregate by BVF, BVF2, and Trading Fund OS, including 62,421 shares held in the Partners managed accounts, which includes 64,870 shares underlying certain Class A Warrants and 64,870 shares underlying certain Class B Warrants. BVF Inc., as the general partner of Partners, may be deemed to beneficially own the 4,274,965 shares beneficially owned by Partners. Mark N. Lampert, as a director and officer of BVF Inc., may be deemed to beneficially own the 4,274,965 shares beneficially owned by BVF Inc. The address for BVF, BVF GP, BVF2, BVF2 GP, BVF GPH, Partners, BVF Inc. and Mark N. Lampert is 44 Montgomery Street, 40th Floor, San Francisco, CA 94104. The address of Trading Fund OS and Partners OS is PO Box 309 Ugland House, Grand Cayman, KY1-1104, Cayman Islands.
(4)
This information is based solely upon a Schedule 13G filed with the SEC on February 17, 2021 by Consonance Capital Management LP (“Consonance”). Consonance Capital Master Account LP (“Consonance Master”) directly holds 1,753,534 shares of common stock (the “Master Account Shares”). Consonance is the investment adviser of Consonance Master, and pursuant to an investment advisory agreement (the “Advisory Agreement”), Consonance exercises voting and investment power over the Master Account Shares held by Consonance Master. Each of Consonance, Consonance Capman GP LLC (“Capman”) and Mr. Blutt may be deeded to beneficially own the Master Account Shares. Consonance Capital Opportunity Master Fund, LP (Consonance Opportunity Master) directly holds 707,743 shares of common stock (the “Opportunity Master Account Shares”). Consonance is the investment adviser of Consonance Opportunity Master, and pursuant to an investment advisory agreement, Consonance exercises voting and investment power over the Opportunity Master Account Shares held by Consonance Opportunity Master. Each of Consonance, Capman and Mr. Blutt may be deemed to beneficially own the Opportunity Master Account Shares. A managed account managed by Consonance Capital Opportunity Fund Management LP (“Consonance Opportunity”) directly holds 268,432 shares of common stock (the “Managed Account Shares”). Capman is the general partner of Consonance Opportunity and Mr. Blutt, as the Manager and Member of Capman, may be deemed to control Capman and Consonance Opportunity. Each of Consonance Opportunity, Capman and Mr. Blutt may be deemed to beneficially own the Managed Account Shares. The address for the Consonance Master, Consonance, Consonance Opportunity, Mr. Blutt and Capman is 1370 Avenue of the America, Suite 3301, New York, New York 10019.
(5)
This information is based solely upon Amendment No. 3 to Schedule 13G/A jointly filed with the SEC on February 16, 2021 by the following entities and persons: (i) Farallon Partners, L.L.C. (“Farallon General Partner”); (ii) Farallon Institutional (GP) V, L.L.C. (“FCIP V General Partner”); and (iii) Philip D. Dreyfuss, Michael B. Fisch, Richard B. Fried, David T. Kim, Michael G. Linn, Rajiv A. Patel, Thomas G. Roberts, Jr., William Seybold, Andrew J. M. Spokes, John R. Warren and Mark C. Wehrly (collectively, the “Farallon Individual Reporting Persons”). Consists of 687,600 shares held by Farallon Capital Partners, L.P. (“FCP”), 834,300 shares held by Farallon Capital Institutional Partners, L.P. (“FCIP”), 147,400 shares held by Farallon Capital Institutional Partners II, L.P. (“FCIP II”), 92,700 shares held by Farallon Capital Institutional Partners III, L.P. (“FCIP III”), 128,700 shares held by Four Crossings Institutional Partners V, L.P. (“FCIP V”), 1,862,361 shares held by Farallon Capital Offshore Investors II, L.P. (“FCOI II”), 48,100 shares held by Farallon Capital (AM) Investors, L.P. (“FCAMI”), and 123,839 shares held by Farallon Capital F5 Master I, L.P. (“F5”) (collectively FCP, FCIP, FCIP II, FCIP III, FCIP V, FCOI II, FCAMI, and F5 are the “Farallon Funds”). Farallon General Partner, as the (i) general partner of each of FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI, and (ii) the sole member of the FCIP V General Partner, is deemed to be the beneficial owner of 3,801,161shares, including 1,462,500 shares for which Warrants are currently exercisable. The Farallon Individual Reporting Persons, each of whom is a managing member of the Farallon General Partner, a manager or senior manager, as the case may be, of the FCIP V General Partner, are each deemed to beneficially own 3,925,000 shares including 1,500,000 shares for which Warrants currently are exercisable. The address of the principal business office of the beneficial owners is c/o Farallon Capital Management, L.L.C., One Maritime Plaza, Suite 2100, San Francisco, CA 94111.
(6)
This information is based solely upon Amendment No. 5 to a Schedule 13G/A filed jointly with the SEC by FMR LLC and Abigail P. Johnson on February 8, 2021 The filing reports that FMR LLC held sole voting power over 778,382 shares and no shared voting power and sole dispositive power of 6,452,764 shares and no shared dispositive power. Abigail P. Johnson is a director, chairman, the chief executive officer and the president of FMR LLC and has sole dispositive power over 6,452,764 shares. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B stockholders have entered into a stockholders’ voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the stockholders’ voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, as amended (the “Investment Company Act”), to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act (the “Fidelity Funds”) advised by Fidelity Management & Research Company (“FMR Co.”), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds’ Boards of Trustees. FMR Co. carries out the voting of the shares under written guidelines established by the Fidelity Funds’ Boards of Trustees. The address for FMR LLC is 245 Summer Street, Boston, MA 02210.
(7)
This information is based solely upon Amendment No. 1 to Schedule 13G filed jointly with the SEC by Johnson & Johnson (“J&J”), and Johnson & Johnson Innovation-JJDC, Inc. (“JJDC”) on February 2, 2021. JJDC is a wholly-owned subsidiary of J&J. The securities held by J&J and JJDC are directly beneficially owned by JJDC. J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC. The board of directors of JJDC, which consists of Paulus Stoffels and Steven Rosenberg, has shared investment and voting control with respect to the shares held by JJDC and has delegated responsibility therefor to the management of JJDC to take such actions on behalf of JJDC. As such, no individual member of the JJDC board of directors is deemed to hold any beneficial ownership or reportable pecuniary interest in the shares held by JJDC. No individual representative of JJDC shall be deemed (i) a beneficial owner of, or (ii) to have a reportable pecuniary interest in, the shares held by JJDC. The address of J&J is One Johnson & Johnson Plaza, New Brunswick, NJ 08933. The address of JJDC is 410 George Street, New Brunswick, NJ 08901.